Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease-Reference-Cited by-同舟云学术

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Published:2000-02 Issue:2 Volume:14 Page:171-176
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Fellermann ,Steffen ,Stein ,Raedler ,Hämling ,Ludwig ,Loeschke ,Stange

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2000.00695.x/fullpdf

Reference26 articles.

1. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis;Pearson;Ann Intern Med,1995

2. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate;Sandborn;Am J Gastroenterol,1996

3. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation;The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group;Transplant,1996

4. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients;Sollinger;Transplant,1995

5. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection;European Mycophenolate Mofetil Cooperative Study Group;Lancet,1995

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Remission in Severe Refractory Crohn’s Disease With Mycophenolate Mofetil;Inflammatory Bowel Diseases;2022-10-12

2. Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis;Clinics and Research in Hepatology and Gastroenterology;2022-08

3. Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis—still a long way to go! Authors' reply;Alimentary Pharmacology & Therapeutics;2022-01-17

4. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry;Digestive and Liver Disease;2021-11

5. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus;World Journal of Gastroenterology;2020-11-21